Bell Katharina, Wilding Corina, Funke Sebastian, Pfeiffer Norbert, Grus Franz H
Experimental Ophthalmology, Department of Ophthalmology, University Medical center of the Johannes Gutenberg University, Langenbeckstraße 1, 55131, Mainz, Germany.
BMC Ophthalmol. 2015 Jun 27;15:64. doi: 10.1186/s12886-015-0044-9.
Previous studies demonstrate changes of autoantibody concentrations against retinal and optic nerve head antigens in the serum of glaucoma patients in comparison to healthy persons. These antibodies belong to the natural autoimmunity. Previous studies showed up regulated, but also significantly down-regulated autoantibody levels. These antibodies have the ability to influence protein profiles of neuroretinal cells and possibly hold neuroprotective potential, as we have been able to demonstrate before. Aim of this study was to analyse the serum and antibody effect of glaucoma patients on neuroretinal cells in more detail and also determine the impact of antibodies found down-regulated in glaucoma patients on the pathogenesis of the neurodegenerative disease glaucoma.
Neuroretinal cells (RGC-5) were incubated with serum either from glaucoma patients or healthy controls for 24 h. Mass spectrometric analysis was performed after cell lysis. Furthermore the neuroretinal cells were preincubated with different and concentrations of 14-3-3 antibodies (0.005, 0.1, 0.5, 1, 5 and 10 μg/ml) and then stressed with H2O2, staurosporine or glutamate. Viability tests were performed with crystal violet and ROS tests with DCFH-DA. Antibody location in the cell after antibody incubation was performed with immunocytochemical methods. Additionally mass spectrometric analysis was performed with the cells after antibody incubation.
Protein expression analysis with Maldi-Orbitrap MS showed changes in the expression level of regulatory proteins in cells incubated with glaucoma serum, e.g. an up-regulation of 14-3-3 and a down-regulation of Calmodulin. After preincubation of the cells with anti-14-3-3 antibody and stressing the cells, we detected an increase in viability of up to 22 % and a decrease in reactive oxygen species (ROS) of up to 31 %. Proteomic 1 analysis involvement of the mitochondrial apoptosis pathway in this protective effect and immunohistochemical analysis showed an antibody uptake in the cells.
We found significant effects of serum antibodies on proteins of neuroretinal cells especially of the mitochondrial apoptosis pathway. Furthermore we detected a protective potential of antibodies down-regulated in glaucoma patients. The changed autoantibodies belong to the natural autoimmunity. We conclude that changes in the natural autoimmunity of patients with glaucoma can negatively impact regulatory functions.
先前的研究表明,与健康人相比,青光眼患者血清中针对视网膜和视神经乳头抗原的自身抗体浓度发生了变化。这些抗体属于天然自身免疫。先前的研究显示自身抗体水平有上调,但也有显著下调。正如我们之前所证明的,这些抗体有能力影响神经视网膜细胞的蛋白质谱,并且可能具有神经保护潜力。本研究的目的是更详细地分析青光眼患者的血清和抗体对神经视网膜细胞的影响,并确定在青光眼患者中发现的下调抗体对神经退行性疾病青光眼发病机制的影响。
将神经视网膜细胞(RGC-5)与青光眼患者或健康对照者的血清孵育24小时。细胞裂解后进行质谱分析。此外,将神经视网膜细胞与不同浓度的14-3-3抗体(0.005、0.1、0.5、1、5和10μg/ml)预孵育,然后用H2O2、星形孢菌素或谷氨酸进行应激处理。用结晶紫进行活力测试,用DCFH-DA进行活性氧测试。抗体孵育后用免疫细胞化学方法检测细胞内抗体的定位。另外,抗体孵育后对细胞进行质谱分析。
用基质辅助激光解吸电离-轨道阱质谱(Maldi-Orbitrap MS)进行的蛋白质表达分析显示,与青光眼血清孵育的细胞中调节蛋白的表达水平发生了变化,例如14-3-3上调,钙调蛋白下调。用抗14-3-3抗体预孵育细胞并对细胞进行应激处理后,我们检测到细胞活力增加高达22%,活性氧(ROS)减少高达31%。蛋白质组学分析表明线粒体凋亡途径参与了这种保护作用,免疫组织化学分析显示细胞摄取了抗体。
我们发现血清抗体对神经视网膜细胞的蛋白质,尤其是线粒体凋亡途径的蛋白质有显著影响。此外,我们检测到青光眼患者中下调的抗体具有保护潜力。这些变化的自身抗体属于天然自身免疫。我们得出结论,青光眼患者天然自身免疫的变化可能会对调节功能产生负面影响。